News | June 03, 2022
LEO Pharma strengthens its commercial organization
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
It is currently available in tablet and injectable dosage forms
Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
Subscribe To Our Newsletter & Stay Updated
